Methods and compositions for derepression of IAP-inhibited caspase

Details for Australian Patent Application No. 2002359457 (hide)

Owner The Burnham Institute Torrey Pines Institute for Molecular Studies

Inventors Ostresh, John M; Houghten, Richard A; Reed, John C; Welsh, Kate; Nefzi, Adel; Pinilla, Clemencia

Agent Griffith Hack

Pub. Number AU-B-2002359457

PCT Number PCT/US02/37577

PCT Pub. Number WO2003/045974

Priority 60/331,957 21.11.01 US

Filing date 21 November 2002

Wipo publication date 10 June 2003

Acceptance publication date 19 April 2007

International Classifications

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/16 (2006.01) Drugs for disorders of the endocrine system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 21/04 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 5/10 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/103 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/107 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/11 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/117 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 7/04 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C12Q 1/37 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving peptidase or proteinase

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 60/331,957 21.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002359457

21 October 2004 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 01 Sep 2004

19 April 2007 Application Accepted

  Published as AU-B-2002359457

23 August 2007 Standard Patent Sealed

17 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002359458-ALANYL-PIPERIDINE HETEROCYCLIC DERIVATIVES USEFUL AGAINST CARDIOVASCULAR DISEASES

2002359456-DISPLAY APPARATUS INCLUDING RGB COLOR COMBINER AND 1D LIGHT VALVE RELAY INCLUDING SCHLIEREN FILTER